Education
About Us
Working with TipRanks
Follow Us
Syncom Formulation (India) Ltd. (IN:SYNCOMF)
:SYNCOMF
SYNCOMF Stock Chart & Stats
₹16.73
-₹0.26(-1.33%)
At close: 4:00 PM EST
₹16.73
-₹0.26(-1.33%)
Day’s Range― - ―
52-Week Range₹14.10 - ₹23.95
Previous CloseN/A
Volume2.15M
Average Volume (3M)249.72K
Market Cap
₹15.38B
Enterprise Value₹19.72B
Total Cash (Recent Filing)₹899.28M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)26.7
Beta1.43
Next Earnings
Nov 13, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 09, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)0.17
Shares Outstanding940,000,000
10 Day Avg. Volume232,913
30 Day Avg. Volume249,719
Financial Highlights & Ratios
PEG Ratio0.27
Price to Book (P/B)4.34
Price to Sales (P/S)3.19
P/FCF Ratio110.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Syncom Formulation (India) Ltd. News
SYNCOMF FAQ
What was Syncom Formulation (India) Ltd.’s price range in the past 12 months?
Syncom Formulation (India) Ltd. lowest stock price was ₹14.10 and its highest was ₹23.95 in the past 12 months.
What is Syncom Formulation (India) Ltd.’s market cap?
Syncom Formulation (India) Ltd.’s market cap is ₹15.38B.
When is Syncom Formulation (India) Ltd.’s upcoming earnings report date?
Syncom Formulation (India) Ltd.’s upcoming earnings report date is Nov 13, 2025 which is in 19 days.
How were Syncom Formulation (India) Ltd.’s earnings last quarter?
Syncom Formulation (India) Ltd. released its earnings results on Aug 08, 2025. The company reported ₹0.168 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.168.
Is Syncom Formulation (India) Ltd. overvalued?
According to Wall Street analysts Syncom Formulation (India) Ltd.’s price is currently Overvalued.
Does Syncom Formulation (India) Ltd. pay dividends?
Syncom Formulation (India) Ltd. pays a Notavailable dividend of ₹0.03 which represents an annual dividend yield of N/A. See more information on Syncom Formulation (India) Ltd. dividends here
What is Syncom Formulation (India) Ltd.’s EPS estimate?
Syncom Formulation (India) Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Syncom Formulation (India) Ltd. have?
Syncom Formulation (India) Ltd. has 940,000,000 shares outstanding.
What happened to Syncom Formulation (India) Ltd.’s price movement after its last earnings report?
Syncom Formulation (India) Ltd. reported an EPS of ₹0.168 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.293%.
Which hedge fund is a major shareholder of Syncom Formulation (India) Ltd.?
Currently, no hedge funds are holding shares in IN:SYNCOMF
Company Description
Syncom Formulation (India) Ltd.
Syncom Formulation (India) Ltd. (SYNCOMF) is a prominent player in the pharmaceutical and healthcare industry, primarily focused on the development, manufacturing, and marketing of a wide range of formulations and active pharmaceutical ingredients (APIs). The company operates in diverse sectors, including generic pharmaceuticals, over-the-counter (OTC) products, and nutraceuticals, catering to both domestic and international markets. With a commitment to quality and innovation, SyncomF specializes in producing cost-effective and high-quality formulations that are essential for various therapeutic areas.
Technical Analysis
GRP Ltd
―
Knowledge Marine & Engineering Works Limited
―
Media Matrix Worldwide Limited
―
Updater Services Limited
―
Uniparts India Ltd.
―